Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study

被引:9
|
作者
Crous-Bou, Marta [1 ,2 ,3 ]
Porta, Miquel [1 ,2 ,3 ]
Morales, Eva [1 ]
Lopez, Tomas [1 ,3 ]
Carrato, Alfredo [4 ]
Puigdomenech, Elisa [1 ,2 ,3 ]
Real, Francisco X. [1 ,5 ,6 ]
机构
[1] Univ Autonoma Barcelona, Clin & Mol Epidemiol Canc Unit, IMIM, Barcelona 08003, Spain
[2] Univ Autonoma Barcelona, Fac Med, Barcelona 08003, Spain
[3] CIBERESP, Barcelona, Spain
[4] Univ Miguel Hernandez, Hosp Univ Elche, Alacant, Spain
[5] Ctr Nacl Invest Oncol, Madrid, Spain
[6] Univ Pompeu Fabra, Barcelona, Spain
关键词
Medical conditions; Diabetes mellitus; Pancreatitis; Peptic ulcer; Pancreatic ductal adenocarcinoma; Pancreatic neoplasms; Etiology; K-ras oncogene; RISK-FACTORS; LIFE-STYLE; CODON; 12; CANCER; HISTORY; INFLAMMATION; ASSOCIATION; P53; EPIDEMIOLOGY; METAANALYSIS;
D O I
10.1007/s10552-008-9267-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In pancreatic ductal adenocarcinoma (PDA) evidence on the etiopathogenic role of past medical conditions in the occurrence and persistence of K-ras mutations is scant. Incident cases of PDA were interviewed face-to-face about past medical history and other factors. Logistic regression was used to compare PDA cases (n = 120) with wild-type and mutated K-ras tumors (case-case study). Patients with wild-type K-ras tumors were more likely to have a prior diagnosis of pancreatitis (Odds ratio [OR] = 6.11, p = 0.041). Diabetes mellitus (DM) was non-significantly more common among cases with a K-ras wild-type tumor, and the OR for DM of > 6 years of duration was 4.54 (p = 0.39). Patients with wild-type K-ras were significantly more likely to have had a surgically treated peptic ulcer (OR = 9.03, p = 0.027). The probability of having a K-ras wild-type tumor increased with the number of medical conditions (p for trend = 0.012); the corresponding OR for two or more medical conditions was 4.46 (95% CI: 1.37-14.50). Results raise the hypothesis that pancreatitis and possibly peptic ulcer might influence pancreatic carcinogenesis through pathways independent of K-ras mutation, perhaps related to growth factors or mediators of the inflammatory response. Large unselected studies should be conducted to refute or replicate our findings.
引用
收藏
页码:591 / 599
页数:9
相关论文
共 50 条
  • [21] Up-Regulation of Prion Protein Associated with K-Ras Mutation in Pancreatic Ductal Adenocarcinoma
    Kletecka, C.
    Li, Q.
    Xin, W.
    Zhou, L.
    MODERN PATHOLOGY, 2010, 23 : 360A - 360A
  • [22] EGF Receptor Signaling Is Essential for K-Ras Oncogene-Driven Pancreatic Ductal Adenocarcinoma
    Navas, Carolina
    Hernandez-Porras, Isabel
    Schuhmacher, Alberto J.
    Sibilia, Maria
    Guerra, Carmen
    Barbacid, Mariano
    CANCER CELL, 2012, 22 (03) : 318 - 330
  • [23] Up-Regulation of Prion Protein Associated with K-Ras Mutation in Pancreatic Ductal Adenocarcinoma
    Kletecka, C.
    Li, Q.
    Xin, W.
    Zhou, L.
    LABORATORY INVESTIGATION, 2010, 90 : 360A - 360A
  • [24] K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines
    Erill, N
    Cuatrecasas, M
    Sancho, FJ
    Farre, A
    Pour, PM
    Lluis, F
    Capella, G
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (04): : 1333 - 1339
  • [25] Oncogenesis and the Clinical Significance of K-ras in Pancreatic Adenocarcinoma
    Huang, Chun
    Wang, Wei-Min
    Gong, Jian-Ping
    Yang, Kang
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (05) : 2699 - 2701
  • [26] A prospective study of K-ras mutations in the plasma of pancreatic cancer patients
    Mulcahy, HE
    Lyautey, J
    Lederrey, C
    Chen, XQ
    Anker, P
    Alstead, EM
    Ballinger, A
    Farthing, MJG
    Stroun, M
    CLINICAL CANCER RESEARCH, 1998, 4 (02) : 271 - 275
  • [27] The Role of K-ras Mutations in Pancreatic Neuroendocrine Tumors
    Gilliland, K.
    Dong, H. J.
    Hochwald, S.
    Liu, C.
    MODERN PATHOLOGY, 2010, 23 : 355A - 356A
  • [28] The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium
    Lüttges, J
    Schlehe, B
    Menke, MAOH
    Vogel, I
    Henne-Bruns, D
    Klöppel, G
    CANCER, 1999, 85 (08) : 1703 - 1710
  • [29] Identification of K-ras mutations in pancreatic juice - Reply
    Berthelemy, P
    Bouisson, M
    Pradayrol, L
    ANNALS OF INTERNAL MEDICINE, 1996, 124 (11) : 1014 - 1015
  • [30] The Role of K-ras Mutations in Pancreatic Neuroendocrine Tumors
    Gilliland, K.
    Dong, H. J.
    Hochwald, S.
    Liu, C.
    LABORATORY INVESTIGATION, 2010, 90 : 355A - 356A